Services that require precertification - ibxtpa
• ®Botox (onabotulinumtoxinA) • Dysport® (abobotulinumtoxinA) • ®Myobloc (rimabotulinumtoxinB) • Xeomin® (incobotulinumtoxinA) Chemotherapy-induced nausea and vomiting (CINV) agents • ®Sustol (Granisetron Extended-release for Injection) Specialty drugs that require precertification
Download Services that require precertification - ibxtpa
Information
Domain:
Source:
Link to this page:
Documents from same domain
Services that require precertification - IBXTPA
www.ibxtpa.comGenetic and genomic tests requiring precertification The following list is a guide to the types of genetic and genomic tests that require precertification.
HIPAA Transaction Standard Companion Guide
www.ibxtpa.comDecember 2013 • 005010 v1.1 1 Independence Administrators HIPAA Transaction Standard Companion Guide Refers to the Implementation Guides Based on …
BlueCard Worldwide Brochure - IBXTPA
www.ibxtpa.comN20-07-011 Important Call the BlueCard Worldwide Service Center at 1.800.810.BLUE (2583) or call collect at 1.804.673.1177 to locate doctors and hospitals, or obtain medical
AmeriHealth Administrators – iExchange Training
www.ibxtpa.com© 2015 Medecision, Inc. Proprietary and Confidential . Frequently Asked Questions » About iExchange » Aerial™ iExchange® (iExchange) is our
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION BOTOX
media.allergan.comJun 20, 2019 · BOTOX® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 _____RECENT MAJOR CHANGES_____ Indications and Usage, Pediatric Detrusor Overactivity associated with a
APPLICATION FOR BOTOX® (onabotulinumtoxinA)
www.abbvie.com©2021 AbbVie B-APP1-21I-2 September 2021 FAX: 1-866-217-7178 PHONE: 1-800-442-6869 APPLICATION FOR BOTOX® (onabotulinumtoxinA) 6 HIPAA AUTHORIZATION, PATIENT TERMS OF PARTICIPATION AND PRIVACY NOTICE HIPAA AUTHORIZATION Please provide signature in Section 5 of Enrollment Form
Procedures, programs and drugs that require …
www.aetna.comBotox (onabotulinumtoxinA) Dysport (abobotulinumtoxinA) Myobloc (rimabotulinumtoxinB) Xeomin (incobotulinumtoxinA) Cablivi (caplacizumab-yhdp) Calcitonin Gene-Related Peptide (CGRP) receptor inhibitors . Vyepti (eptinezumab-jjmr) — precertification for the drug and site of care required . Cardiovascular — PCSK9 inhibitors:
for Blepharospasm - BOTOX® (onabotulinumtoxinA) for ...
www.botoxmedical.com2 It is essential to diagnose and code correctly for BOTOX® (onabotulinumtoxinA) therapy service(s) to help ensure timely and adequate reimbursement. a The descriptor for J0585 requires that BOTOX® be billed by number of Units, not number of vials. b
Billing and Coding - BOTOX® (onabotulinumtoxinA) for ...
www.botoxmedical.com(onabotulinumtoxinA) indications. IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING. WARNING: DISTANT SPREAD OF TOXIN EFFECT Postmarketing reports indicate that the effects of BOTOX ® and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects.
2020 Table of Drugs - CMS
www.cms.govOct 22, 2019 · Botox, see OnabotulinumtoxinA Brentuximab Vedotin 1 mg IV J9042 Brethine, see Terbutaline sulfate or Terbutaline, compounded Bricanyl Subcutaneous, see Terbutaline sulfate Brolucizumab- dbll 1 mg OTH J0179 Brompheniramine …
FINAL RULE: CMS-1717-FC: PRIOR AUTHORIZATION PROCESS …
www.cms.govJ0585 Injection, onabotulinumtoxina, 1 unit 1 Prior authorization is only required when one of the required Botulinum Toxin codes (J0585, J0586, J0587, or J0588) is used in conjunction with the one of the required CPT injection codes (64612, injection of chemical for